Treatment of advanced neuroendocrine tumors: Results of the UKINETS and NCRI randomized phase II NET01 trial.
Philippa Corrie
No relevant relationships to disclose
Martyn Caplin
No relevant relationships to disclose
Nicholas Reed
No relevant relationships to disclose
Wendi Qian
No relevant relationships to disclose
Si-houy Lao-Sirieix
No relevant relationships to disclose
Richard Hardy
No relevant relationships to disclose
Graham Armstrong
No relevant relationships to disclose
Juan W. Valle
No relevant relationships to disclose
Denis Charles Talbot
No relevant relationships to disclose
David Cunningham
Consultant or Advisory Role - Amgen (U); Roche (U)
Research Funding - Amgen; AstraZeneca; Roche
Expert Testimony - Amgen (U)
Tu Vinh Luong
No relevant relationships to disclose
Ashley Shaw
No relevant relationships to disclose
Tim Meyer
No relevant relationships to disclose